Tianfeng Chen

21.2k total citations · 2 hit papers
416 papers, 17.9k citations indexed

About

Tianfeng Chen is a scholar working on Biomedical Engineering, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Tianfeng Chen has authored 416 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Biomedical Engineering, 129 papers in Molecular Biology and 114 papers in Nutrition and Dietetics. Recurrent topics in Tianfeng Chen's work include Nanoplatforms for cancer theranostics (137 papers), Selenium in Biological Systems (111 papers) and Nanoparticle-Based Drug Delivery (48 papers). Tianfeng Chen is often cited by papers focused on Nanoplatforms for cancer theranostics (137 papers), Selenium in Biological Systems (111 papers) and Nanoparticle-Based Drug Delivery (48 papers). Tianfeng Chen collaborates with scholars based in China, Hong Kong and United States. Tianfeng Chen's co-authors include Wenjie Zheng, Lizhen He, Yum‐Shing Wong, Yum-Shing Wong, Yanyu Huang, Haoqiang Lai, Xiaoling Li, Cundong Fan, Yuanyuan You and Yibo Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Tianfeng Chen

408 papers receiving 17.7k citations

Hit Papers

Highly bioactive zeolitic imidazolate framework-8–capped ... 2020 2026 2022 2024 2020 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianfeng Chen China 77 5.4k 4.7k 4.7k 4.4k 2.7k 416 17.9k
Tianli Yue China 77 2.4k 0.4× 7.3k 1.6× 3.1k 0.7× 1.9k 0.4× 1.0k 0.4× 637 22.4k
Ali Akbar Saboury Iran 61 1.8k 0.3× 7.7k 1.6× 2.9k 0.6× 1.3k 0.3× 1.7k 0.6× 548 16.0k
Balaraman Kalyanaraman United States 89 2.0k 0.4× 13.4k 2.8× 2.4k 0.5× 1.5k 0.4× 688 0.3× 349 30.8k
Jun‐Jie Yin United States 71 4.5k 0.8× 5.5k 1.2× 10.0k 2.1× 484 0.1× 1.1k 0.4× 252 18.2k
Albert W. Girotti United States 49 5.2k 1.0× 7.6k 1.6× 2.9k 0.6× 1.5k 0.3× 490 0.2× 172 18.3k
Wenjie Zheng China 53 1.4k 0.3× 1.8k 0.4× 1.8k 0.4× 2.5k 0.6× 732 0.3× 169 8.2k
Peng Huang China 82 2.6k 0.5× 18.0k 3.8× 1.6k 0.3× 957 0.2× 1.0k 0.4× 329 31.3k
Tomohiro Sawa Japan 48 3.5k 0.6× 6.1k 1.3× 1.3k 0.3× 395 0.1× 4.1k 1.5× 211 14.9k
Vince Castranova United States 48 2.5k 0.5× 3.9k 0.8× 3.2k 0.7× 608 0.1× 2.1k 0.8× 91 11.4k
Huibi Xu China 56 1.9k 0.3× 2.6k 0.5× 2.2k 0.5× 691 0.2× 1.6k 0.6× 208 10.3k

Countries citing papers authored by Tianfeng Chen

Since Specialization
Citations

This map shows the geographic impact of Tianfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianfeng Chen more than expected).

Fields of papers citing papers by Tianfeng Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianfeng Chen. The network helps show where Tianfeng Chen may publish in the future.

Co-authorship network of co-authors of Tianfeng Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tianfeng Chen. A scholar is included among the top collaborators of Tianfeng Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianfeng Chen. Tianfeng Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ting, Shuya Pan, Qingfeng Zhou, et al.. (2025). Selenium nanoparticles restrain recurrence of cervical cancer in drug-free period by inhibiting the expression of ABC transporters. Nano Today. 62. 102692–102692. 1 indexed citations
2.
Huang, Guanning, et al.. (2025). Exploring the Neuroprotective Role of Selenium: Implications and Perspectives for Central Nervous System Disorders. Exploration. 5(4). e20240415–e20240415. 4 indexed citations
3.
Liu, Ting, Zhiming Lin, Xi Zhang, et al.. (2025). Targeting Nanotherapeutics for Highly Efficient Diagnosis and Treatment of Systemic Lupus Erythematosus through Regulation of Immune Response. Small Science. 5(5). 2400521–2400521. 2 indexed citations
4.
Hu, Xiaoli, Zhongwen Yuan, Guanning Huang, et al.. (2025). High‐Valence Selenium Nanotherapeutics Downregulates MUC16 to Drive Precise Ovarian Cancer Therapy through Redox Perturbation. Advanced Functional Materials. 35(22). 4 indexed citations
6.
Zhang, Zhongyang, Wei Huang, Jianfu Zhao, et al.. (2024). MoSe2-based magnetic nanosystem for clinical enrichment, retrieval and elimination of circulating tumor cells. Nano Today. 57. 102330–102330. 3 indexed citations
7.
Li, Zhi, Shuya Pan, Shaowei Liu, et al.. (2024). Selenium nanoparticles enhance the chemotherapeutic efficacy of pemetrexed against non-small cell lung cancer. Chinese Chemical Letters. 35(12). 110018–110018. 4 indexed citations
8.
Chen, Mingkai, et al.. (2024). Chirality-driven strong thioredoxin reductase inhibition. Biomaterials. 311. 122705–122705. 6 indexed citations
9.
Hu, Qian, Yanan Zhao, Wan‐Yang Sun, et al.. (2024). CK-666 protects against ferroptosis and renal ischemia-reperfusion injury through a microfilament-independent mechanism. Journal of Biological Chemistry. 300(12). 107942–107942. 1 indexed citations
10.
Ma, Li, Yanni He, Yanzhou Chang, et al.. (2024). Ultrasound-triggered functional hydrogel promotes multistage bone regeneration. Biomaterials. 311. 122650–122650. 19 indexed citations
11.
12.
Xu, Yanchao, Haoqiang Lai, Shuya Pan, et al.. (2023). Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation. Biomaterials. 305. 122452–122452. 20 indexed citations
13.
Huang, Wei, Lizhen He, Shiqing Nie, et al.. (2023). Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment. Nano Today. 50. 101819–101819. 16 indexed citations
14.
Chan, Leung, Yongkang Liu, Yanhong Su, et al.. (2023). Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu2‐xSe via Copper Chemical Transition. Advanced Functional Materials. 33(33). 57 indexed citations
15.
Qin, Xiaoyu, et al.. (2023). Dimension-driven cobalt porphyrin nanoframework mimics dehydrogenase activity for inhibition of cancer proliferation. Surfaces and Interfaces. 37. 102709–102709. 3 indexed citations
16.
Jin, Guoqing, Haoqiang Lai, Zi‐Shu Yang, et al.. (2022). Gadolinium(III) Porphyrinoid Phototheranostics. Chemistry - An Asian Journal. 17(10). e202200181–e202200181. 7 indexed citations
17.
Yuan, Zhongwen, Xinxin Liu, Guanning Huang, et al.. (2022). In situ-transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis. Biomaterials. 287. 121620–121620. 59 indexed citations
18.
Li, Yan Yan, et al.. (2019). Bifunctional Gyroidal MOFs: Highly Efficient Lewis Base and Lewis Acid Catalysts. Chemistry - An Asian Journal. 14(20). 3682–3687. 16 indexed citations
19.
Fan, Cundong, Qiong Wu, Tianfeng Chen, et al.. (2014). Arene ruthenium( ii ) complexes induce S-phase arrest in MG-63 cells through stabilization of c-Myc G-quadruplex DNA. MedChemComm. 5(5). 597–602. 38 indexed citations
20.
Liu, Chaoran, Zhong Liu, Meng Li, et al.. (2013). Enhancement of Auranofin-Induced Apoptosis in MCF-7 Human Breast Cells by Selenocystine, a Synergistic Inhibitor of Thioredoxin Reductase. PLoS ONE. 8(1). e53945–e53945. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026